Importantly, our strategy was able to rediscover 16 previously identified fusion transcripts in ovarian cancer such as LAMC2-NMNAT2 and MAG-CD22[6], indicating that the method is effective. This evidence concerns the gene CD22 and ovarian carcinoma.